Point-of-Care Lung Ultrasound Predicts Severe Disease and Death Due to COVID-19: A Prospective Cohort Study.

ABSTRACT: The clinical utility of point-of-care lung ultrasound (LUS) among hospitalized patients with COVID-19 is unclear.

Design

Prospective cohort study.

Setting

A large tertiary care center in Maryland, between April 2020 and September 2021.

Patients

Hospitalized adults (≥ 18 yr old) with positive severe acute respiratory syndrome coronavirus 2 reverse transcriptase-polymerase chain reaction results.

Interventions

None.

Measurements and main results

All patients were scanned using a standardized protocol including 12 lung zones and followed to determine clinical outcomes until hospital discharge and vital status at 28 days. Ultrasounds were independently reviewed for lung and pleural line artifacts and abnormalities, and the mean LUS Score (mLUSS) (ranging from

SUBMITTER: Blair PW 

PROVIDER: S-EPMC9377680 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature